Showing results (141-150 of 195) with videos related to

Sort By:
Pageof 20
Cancer Investigation|January 1, 1991
Evaluation of two consecutive regimens in advanced gastric cancerF Figoli, E Galligioni, D Crivellari, et al.
Cancer Detection and Prevention|January 1, 1988
Clinical and laboratory findings at presentation in persistent generalized lymphadenopathy vs malignant lymphomaV Zagonel, U Tirelli, E Vaccher, et al.
European Journal of Cancer (Oxford, England : 1990)|June 5, 2004
RFS2000 (9-nitrocamptothecin) in advanced small cell lung cancer, a phase II study of the EORTC New Drug Development GroupC J A Punt, M J A de Jonge, S Monfardini, et al.
Breast Cancer Research and Treatment|November 4, 2005
Multicenter phase II study of trastuzumab in combination with epirubicin and docetaxel as first-line treatment for HER2-overexpressing metastatic breast cancerM Venturini, C Bighin, S Monfardini, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Mitomycin C treatment of advanced, hormone-resistant prostatic carcinoma: a phase II studyA Veronesi, V Dal Bo, G Lo Re, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Multimodal treatment of locally advanced transitional cell bladder carcinoma in elderly patientsA Veronesi, G Lo Re, A Carbone, et al.
European Journal of Cancer & Clinical Oncology|October 1, 1987
Sequential combination of tamoxifen and high dose medroxyprogesterone acetate: therapeutic and endocrine effects in postmenopausal advanced breast cancer patientsG Gasparini, L Canobbio, E Galligioni, et al.
Cancer|January 15, 1994
Combined antineoplastic and antiretroviral therapy for patients with Hodgkin's disease and human immunodeficiency virus infection. A prospective study of 17 patients. The Italian Cooperative Group on AIDS and Tumors (GICAT)D Errante, U Tirelli, R Gastaldi, et al.
Cancer|January 5, 2000
Chemotherapy in patients with recurrent and progressive central neurocytomaA A Brandes, P Amistà, M Gardiman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1995
CD30 (Ki-1)-positive anaplastic large-cell lymphomas in 13 patients with and 27 patients without human immunodeficiency virus infection: the first comparative clinicopathologic study from a single institution that also includes 80 patients with other human immunodeficiency virus-related systemic lymphomasU Tirelli, E Vaccher, V Zagonel, et al.
Pageof 20